Ketone Body Metabolism — MCQs
Organ that can utilize glucose, fatty acids and ketone bodies is:
What are the products of the isocitrate to α-ketoglutarate conversion in the TCA cycle?
What is the main source of ketone bodies during fasting?
A patient with diabetes mellitus for the past 5 years presents with vomiting and abdominal pain. She is non-compliant with medication and appears dehydrated. Investigations revealed a blood sugar value of 500 mg/dl and the presence of ketone bodies. What is the next best step in management of this patient?
A 24 year old male presents with altered sensorium and rapid shallow breathing. ABG shows:pH 7.2, sodium 140, bicarbonate 10 and chloride 98. Probable diagnosis is -
Ketone body formation without glycosuria is seen in ?
Patient with Type I diabetes mellitus, with complaints of polyuria. Which of the following will occur normally in his body?
All are true about ketone bodies except?
Which protein hormone is often referred to as the 'guardian angel against obesity' due to its role in regulating metabolism?
Which of the following is not a phospholipid ?
Ketone Body Metabolism Indian Medical PG Practice Questions and MCQs
Question 1: Organ that can utilize glucose, fatty acids and ketone bodies is:
- A. Liver
- B. Brain
- C. Skeletal muscle (Correct Answer)
- D. RBC
Explanation: ***Skeletal muscle*** - Skeletal muscle is highly adaptable and can utilize **glucose**, **fatty acids (FAs)**, and **ketone bodies** as fuel sources, especially during prolonged exercise or starvation. - Its metabolic flexibility allows it to switch between these substrates depending on their availability and the body's energy demands. *Liver* - The liver is central to metabolism but primarily **produces ketone bodies** from fatty acids rather than utilizing them as a major fuel source for its own energy needs. - While it uses glucose and FAs, its role in ketone body metabolism is largely synthetic. *Brain* - The brain preferentially uses **glucose** as its primary fuel. - During prolonged starvation, it can adapt to utilize **ketone bodies** as an alternative fuel source, but it does not significantly use fatty acids directly. *RBC* - Red blood cells (RBCs) lack mitochondria and therefore rely exclusively on **anaerobic glycolysis** for energy, metabolizing only **glucose**. - They cannot utilize fatty acids or ketone bodies.
Question 2: What are the products of the isocitrate to α-ketoglutarate conversion in the TCA cycle?
- A. GTP, CO2
- B. NADPH, H2O
- C. FADH2, ATP
- D. NADH, CO2 (Correct Answer)
Explanation: ***NADH, CO2*** - The conversion of **isocitrate to α-ketoglutarate** is an oxidative decarboxylation step catalyzed by **isocitrate dehydrogenase**. - This reaction produces **NADH** (from NAD+) and **carbon dioxide (CO2)**, as a carbon atom is lost. *GTP, CO2* - **GTP** is produced during the conversion of **succinyl-CoA to succinate** in a substrate-level phosphorylation step, not during the isocitrate to α-ketoglutarate conversion. - While CO2 is produced in the latter, GTP is not. *NADPH, H2O* - **NADPH** is primarily generated in the **pentose phosphate pathway** and is used for reductive biosynthesis, not directly produced in the TCA cycle. - **H2O** is consumed or produced in other steps of the TCA cycle but not as a direct product of this specific reaction. *FADH2, ATP* - **FADH2** is produced during the conversion of **succinate to fumarate** by succinate dehydrogenase. - **ATP** (or GTP which can be converted to ATP) is produced in the succinyl-CoA to succinate step, not at the isocitrate dehydrogenase step.
Question 3: What is the main source of ketone bodies during fasting?
- A. Glucose
- B. Amino acids
- C. Glycogen
- D. Fatty acids (Correct Answer)
Explanation: ***Fatty acids*** - During **fasting**, the body shifts from carbohydrate to fat metabolism to produce energy. - **Fatty acids** are broken down in the liver through **beta-oxidation** to form acetyl-CoA, which is then converted into ketone bodies. *Glucose* - **Glucose** is the primary energy source in the fed state, not during fasting. - During fasting, **glucose levels** decrease, prompting the body to seek alternative fuel sources. *Amino acids* - While some **amino acids** can be converted into glucose (gluconeogenesis) or ketone bodies, they are a secondary source. - **Protein breakdown** for energy is primarily a long-term adaptation to starvation, not the main initial source of ketone bodies. *Glycogen* - **Glycogen stores** (mainly in the liver and muscles) are used during the initial hours of fasting. - Once these stores are depleted, usually within 12-24 hours, the body relies on **fatty acid oxidation** for energy, leading to ketone body production.
Question 4: A patient with diabetes mellitus for the past 5 years presents with vomiting and abdominal pain. She is non-compliant with medication and appears dehydrated. Investigations revealed a blood sugar value of 500 mg/dl and the presence of ketone bodies. What is the next best step in management of this patient?
- A. Intravenous fluids
- B. Intravenous insulin
- C. Intravenous fluids with regular insulin (Correct Answer)
- D. Intravenous fluids with long-acting insulin
Explanation: Detailed management of diabetic ketoacidosis (DKA) requires both fluid resuscitation and insulin therapy. ***Intravenous fluids with regular insulin*** - The patient presents with classic signs of **diabetic ketoacidosis (DKA)**: hyperglycemia (blood sugar 500 mg/dl), ketone bodies, dehydration, and a history of diabetes non-compliance [1]. - Initial management for DKA involves aggressive **intravenous fluid resuscitation** to correct dehydration and then **intravenous regular insulin** to lower blood glucose and resolve ketosis [2]. *Intravenous fluids with long-acting insulin* - While fluids are essential, **long-acting insulin** is not appropriate for the acute management of DKA because its slow onset of action makes it inefficient for rapidly correcting hyperglycemia and ketosis. - **Regular insulin** is preferred as it has a quicker onset and shorter duration, allowing for more precise titration in an acute setting [2]. *Intravenous fluids* - Although crucial for correcting **dehydration** and improving renal perfusion, fluids alone will not address the underlying **insulin deficiency** and **ketosis** that define DKA. - Without insulin, the body will continue to produce ketones, exacerbating acidosis [3]. *Intravenous insulin* - Giving intravenous insulin without prior or concomitant **fluid resuscitation** can be dangerous, as it can worsen **hypovolemia** and potentially lead to circulatory collapse by shifting glucose and potassium into cells. - It is critical to first restore **circulating volume** before initiating insulin therapy [2].
Question 5: A 24 year old male presents with altered sensorium and rapid shallow breathing. ABG shows:pH 7.2, sodium 140, bicarbonate 10 and chloride 98. Probable diagnosis is -
- A. Amphetamine toxicity
- B. DKA (Correct Answer)
- C. Renal tubular acidosis
- D. Ethylene glycol poisoning
Explanation: ***DKA*** - The patient presents with **altered sensorium** and **rapid shallow breathing** (Kussmaul breathing), consistent with severe metabolic acidosis [1]. - The ABG results show **pH 7.2** (acidosis), **bicarbonate 10** (metabolic component), and an **elevated anion gap** (Na - (Cl + HCO3) = 140 - (98 + 10) = 32), which are characteristic findings in **diabetic ketoacidosis (DKA)** [1], [2]. *Amphetamine toxicity* - Amphetamine toxicity typically causes **sympathomimetic effects** such as tachycardia, hypertension, hyperthermia, and agitation, rather than directly leading to a high anion gap metabolic acidosis of this severity. - While it can cause some metabolic derangements, the primary acid-base disturbance is usually different or less pronounced in this manner compared to DKA. *Renal tubular acidosis* - Renal tubular acidosis (RTA) typically presents with a **normal anion gap metabolic acidosis** (hyperchloremic metabolic acidosis), where the anion gap would not be significantly elevated. - The calculated anion gap of 32 in this patient rules out RTA as the primary cause of this severe acidosis. *Ethylene glycol poisoning* - Ethylene glycol poisoning also causes a **high anion gap metabolic acidosis** and altered mental status. - However, it is typically associated with additional specific symptoms like **flank pain**, **oliguria**, and detection of **calcium oxalate crystals** in the urine, which are not mentioned in this case.
Question 6: Ketone body formation without glycosuria is seen in ?
- A. Diabetes mellitus
- B. Diabetes insipidus
- C. Starvation (Correct Answer)
- D. Obesity
Explanation: ***Starvation*** - During **starvation**, the body depletes its **glycogen stores** and begins to break down **fat for energy**. This process leads to the production of **ketone bodies** (acetoacetate, beta-hydroxybutyrate, and acetone) as an alternative fuel source for the brain and other tissues. - Since there is no underlying problem with **insulin production** or action, blood glucose levels are typically low or normal, and therefore, **glycosuria** (glucose in the urine) is absent. *Diabetes mellitus* - In **uncontrolled diabetes mellitus**, especially Type 1, the body cannot effectively use **glucose** due to lack of insulin, leading to high blood glucose levels (**hyperglycemia**) and subsequently **glycosuria**. - The body then compensates by breaking down **fats**, leading to the formation of **ketone bodies** (**diabetic ketoacidosis**), which results in both **ketonuria** and **glycosuria**. *Diabetes insipidus* - **Diabetes insipidus** is a condition characterized by the inability to conserve water due to insufficient **antidiuretic hormone (ADH)** production or action, leading to excessive urination and thirst. - It does not involve abnormalities in **glucose metabolism** or **ketone body production** and therefore does not typically present with ketonuria or glycosuria. *Obesity* - While **obesity** can lead to **insulin resistance** and is a risk factor for Type 2 Diabetes, it does not directly cause **ketone body formation** in the absence of metabolic derangements such as those seen in uncontrolled diabetes or prolonged starvation. - In most cases of obesity without diabetes, **glucose metabolism** is still adequate enough to prevent significant reliance on **fat breakdown** for energy, meaning there is usually no ketonuria or glycosuria.
Question 7: Patient with Type I diabetes mellitus, with complaints of polyuria. Which of the following will occur normally in his body?
- A. Increased protein synthesis
- B. Glycogenesis in muscle
- C. Decreased cholesterol synthesis
- D. Increased conversion of fatty acid to acetyl CoA (Correct Answer)
Explanation: ***Increased conversion of fatty acid to acetyl CoA*** - In response to **insulin deficiency** and **hyperglycemia** in Type 1 diabetes, the body shifts from carbohydrate to fat metabolism. - This leads to increased **lipolysis**, releasing fatty acids that are then converted to **acetyl CoA** in the liver for energy or ketone body production. *Incorrect: Increased protein synthesis* - **Insulin** is an **anabolic hormone** that promotes protein synthesis; its deficiency in Type 1 diabetes leads to decreased, not increased, protein synthesis. - Instead, there's often increased **protein catabolism** to provide substrates for gluconeogenesis. *Incorrect: Glycogenesis in muscle* - **Insulin** is required for the uptake of glucose into muscle cells and its subsequent conversion to **glycogen (glycogenesis)**. - In Type 1 diabetes, the lack of insulin significantly impairs muscle glucose uptake and glycogenesis. *Incorrect: Decreased cholesterol synthesis* - In uncontrolled Type 1 diabetes, there is actually **increased cholesterol synthesis**, not decreased. - The increased availability of **acetyl CoA** (from enhanced fatty acid oxidation) provides substrate for cholesterol synthesis via the **HMG-CoA reductase pathway**. - This contributes to the **dyslipidemia** commonly seen in poorly controlled diabetes, including elevated LDL cholesterol and total cholesterol levels.
Question 8: All are true about ketone bodies except?
- A. Synthesized in mitochondria
- B. Acetoacetate is the primary ketone body
- C. HMG CoA reductase is the rate-limiting enzyme (Correct Answer)
- D. Synthesized in liver
Explanation: ***HMG CoA reductase is the rate-limiting enzyme*** - This statement is incorrect. **HMG-CoA reductase** is the rate-limiting enzyme in **cholesterol synthesis**, not ketone body synthesis. - The rate-limiting enzyme in ketogenesis is **HMG-CoA synthase**, which catalyzes the formation of HMG-CoA from acetoacetyl-CoA and acetyl-CoA. *Acetoacetate is the primary ketone body* - **Acetoacetate** is indeed a primary ketone body, along with beta-hydroxybutyrate and acetone. - It is an important energy source for many tissues during periods of **fasting or carbohydrate deprivation**. *Synthesized in mitochondria* - The synthesis of ketone bodies, known as **ketogenesis**, occurs exclusively in the **mitochondria** of liver cells. - This compartment provides the necessary enzymes and substrates, such as **acetyl-CoA**, for the process. *Synthesized in liver* - The **liver** is the primary, if not exclusive, site for **ketone body synthesis**. - While other tissues can oxidize ketone bodies for energy, only the liver possesses the complete enzymatic machinery for their production.
Question 9: Which protein hormone is often referred to as the 'guardian angel against obesity' due to its role in regulating metabolism?
- A. Adiponectin (Correct Answer)
- B. Fibronectin
- C. High-Density Lipoprotein (HDL)
- D. Insulin
Explanation: ***Adiponectin*** - **Adiponectin** is a hormone secreted by **adipose tissue** that plays a crucial role in regulating glucose and fatty acid metabolism, increasing **insulin sensitivity**, and decreasing inflammation. - Its levels are inversely correlated with body fat percentage; individuals with obesity tend to have lower adiponectin levels, leading to its nickname as the 'guardian angel against obesity'. *Fibronectin* - **Fibronectin** is a glycoprotein involved in cell adhesion, growth, migration, and differentiation, and is a key component of the **extracellular matrix**. - It does not primarily function in metabolic regulation or body weight control, unlike adiponectin. *High-Density Lipoprotein (HDL)* - **HDL** is a type of lipoprotein that transports cholesterol from peripheral tissues back to the liver, a process known as **reverse cholesterol transport**. - While beneficial for cardiovascular health, HDL is a lipid-carrying particle, not a protein hormone, and its primary role is not in metabolic regulation or direct obesity prevention. *Insulin* - **Insulin** is a peptide hormone produced by the pancreas that regulates carbohydrate and fat metabolism, primarily by facilitating glucose uptake from the blood into cells. - While essential for metabolism, high levels of insulin in the context of insulin resistance can contribute to obesity, rather than act against it.
Question 10: Which of the following is not a phospholipid ?
- A. Lecithin
- B. Plasmalogen
- C. Cardiolipin
- D. Ganglioside (Correct Answer)
Explanation: ***Ganglioside*** - Gangliosides are a type of **glycosphingolipid** because their structure includes a ceramide (a sphingoid base linked to a fatty acid) and a carbohydrate portion with one or more **sialic acid** residues, but no phosphate group. - They are primarily found in **nerve cell membranes** and are crucial for cell-cell recognition and signaling, differentiating them from phospholipids which contain a phosphate group. *Lecithin* - Lecithin, specifically **phosphatidylcholine**, is a common phospholipid characterized by a **phosphate group** and a **choline head group** attached to a diacylglycerol backbone. - It plays vital roles in cell membrane structure and function and is an important emulsifier. *Plasmalogen* - Plasmalogens are a class of phospholipids characterized by a **vinyl ether linkage** at the *sn*-1 position of the glycerol backbone, instead of the typical ester linkage found in other phospholipids. - They retain the defining **phosphate group** that classifies them as phospholipids. *Cardiolipin* - Cardiolipin is a unique phospholipid composed of **two phosphatidic acid moieties** connected by a glycerol molecule, resulting in four fatty acid chains and two phosphate groups. - It is predominantly found in the **inner mitochondrial membrane**, essential for mitochondrial function.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free